newswire, breaking news for marijuana, cannabis and hemp stocks

Monday 30 December 2019

Investor Ideas Potcasts; Cannabis News and Stocks on the Move; (CSE: $BEV.C), (NASDAQ: $AMRS), (TSXV: $KHRN.V), (CSE: $OILS.C), (TSX: $APHA.TO) (NYSE: $APHA)

Investor Ideas Potcasts; Cannabis News and Stocks on the Move; (CSE: $BEV.C), (NASDAQ: $AMRS), (TSXV: $KHRN.V), (CSE: $OILS.C), (TSX: $APHA.TO) (NYSE: $APHA)

Delta, Kelowna, BC, December 30, 2019 ( Newswire), a global news source covering leading sectors including marijuana and hemp stocks and its potcast site,  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast we look at a few early announcements.

BevCanna Enterprises Inc. (CSE:BEV) (OTCQB: BVNNF) announced that is has increased the size of its outdoor cannabis cultivation site to 292 acres, up from the originally announced 130 acre site. BevCanna has partnered with agricultural experts Clearwater CannGrow Ltd. to grow certified organic sun-grown cannabis on the property near Osoyoos, British Columbia.

This expansion of cultivatable land will allow BevCanna to develop into one of largest outdoor cannabis cultivators in Canada. The Company has in turn increased its anticipated production to 300,000 kg - 400,000 kg of biomass, and a yield of 30,000 kg – 40,000 kg of pure cannabinoids through the finished extract.

"Interest in our BC sun grown cannabis has been exceptionally strong, and we're expanding our cultivation and production capabilities to meet the anticipated demand," said John Campbell, Chief Strategy Officer at BevCanna. "The increased capacity will position BevCanna well to become a leader in the production of high-quality, next-generation products, in the lead-up to Canada's commercialization of such products in 2020."

In conjunction with the additional cultivation capacity, BevCanna has completed a debt settlement with cultivation partner Clearwater CannGrow, in the amount of $500,000, in exchange for the issuance of 1,000,000 common shares at a deemed price of $0.50 per Share.

"We're very pleased to further strengthen our relationship with Clearwater CannGrow," said John Campbell, Chief Strategy Officer at BevCanna. "Clearwater CannGrow's direct expenditures into our agricultural operation are an incredible sign of confidence and commitment to the operation, and to BevCanna as a whole."

The Shares issued in the debt settlement are subject to resale restrictions imposed by applicable law or regulation, including a statutory hold period expiring four months and one day from the date of closing of the debt settlement.

Amyris, Inc. (NASDAQ: AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, reported that it has successfully shipped the first cannabinoid to its partner, LAVVAN. Amyris is also well on its way to the shipment of a second cannabinoid in the first half of 2020.

These ingredients are produced with Amyris's fermentation technology platform delivering the leading quality and high purity at a significantly reduced cost relative to cannabis plant grown and derived ingredients. The company's technology allows Amyris to scale ingredients that are rarer within the cannabis plant, and difficult and extremely expensive to extract in quantity. This is the 10th unique fermentation molecule Amyris has currently in production. Amyris is a market leader in Clean Beauty and natural ingredients from fermentation and currently has 22 additional molecules in development with some of the world's leading companies as partners and long-term supply and commercialization agreements to ensure successful market entry.

The company also announced that it has agreed on business terms for a partnership with a leading Asian pharmaceutical company to develop and scale a breakthrough target for a rare oncology treatment. In addition to the success in cannabinoids and the new opportunity in oncology the company has also agreed to significantly expand its current collaboration with its Chinese partner for vitamins. Amyris plans to provide further details on these agreements at an investor update meeting to be scheduled in February. These new agreements represent several millions of dollars in collaboration payments annually for the next several years. Biossance is also having an excellent quarter with now representing about 50% of Biossance revenue and Sephora continuing to deliver excellent growth.

"We are very pleased to end 2019 with strong operational performance and business momentum," said John Melo, President and CEO of Amyris. "We plan to continue building on our position as the leading synthetic biology company by continuing to deliver the highest purity and most sustainably sourced ingredients for the Health, Beauty and Flavor and Fragrance industries. Our brands are delivering the leading products in their respective categories and this is helping us deliver an excellent quarter. We expect to have our financing needs behind us early in 2020 and a strong year of profitable growth."

Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF)  welcomed the Colombian government's announcement that the country has been awarded a record high quota of 21.84% of worldwide high -THC for commercial and scientific purposes. The quota, which is awarded by the International Narcotics Control Board ("INCB"), an independent body for the implementation of the United Nations Drug Convention, affirms Colombia's role as one of the most important supply sources for the licensed global cannabis economy.

Established in 1961, the INCB, who's members are made up of global government agencies and representatives of the World Health Organization, plays an important role in monitoring enforcement of restrictions on narcotics and psychotropics and in deciding which jurisdictions should be regulated. The quota allocation of 56.5 tons of dry flower for Colombia in 2020, affirms that the international community governing legalized narcotics recognizes the important work of the Colombia government in establishing an effective regulatory framework to support national and worldwide cannabis demand.

Juan Diego Alvarez, Khiron Vice President of Regulatory Affairs, stated "As the only company with an authorized high-THC quota for cultivation in 2019 to meet the needs of patients in Colombia, we welcome the INCB announcement and congratulate the Government of Colombia on the achievement. The 2020 quota guarantees access to new medical products that can transform patients' lives."

Khiron Life Sciences is currently the only cannabis company in Colombia with an allocation of quota to manufacture psychoactive medical cannabis for commercial domestic purposes, and one of the few companies also authorized to meet export demand. As previously announced, the authorization is a result of commercial quotas allocated to Khiron by the Colombian Technical Quotas Group ("TQG"), which permit the Company to cultivate and commercialize up to 560 kg – or approximately, 65,000 units – of psychoactive, high-THC cannabis in 2019. As of April 2019, Khiron has applied for additional commercial quotas for high-THC cannabis for 2020. TQG decisions on commercial quotas for the year are anticipated to be announced by February 2020. 

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) announced that the Canadian Intellectual Property Office has granted the Company a patent for its proprietary filtration stack used in the post-extraction processing of THC and CBD oils. Nextleaf has been issued a total of 11 patents by four international patent offices in the key markets of Canada, the United States of America, Australia, and Colombia.

"Given the abundant supply of lower-grade dried cannabis, we believe processors that establish a competitive advantage by utilizing superior technology to transform otherwise unsellable biomass into high-purity THC and CBD oils at a lower cost than competitors, will generate better margins and build a sustainable long term business," said Paul Pedersen, CEO of Nextleaf Solutions. "As we close out 2019, I'm extremely proud of our R&D team for obtaining its 11th patent, protecting what we believe to be the most efficient methods for producing distilled THC and CBD oil at scale within a regulated environment," continued Pedersen.

Aphria Inc. (TSX: APHA) (NYSE: APHA) will release their financial results for its second quarter and six months ended November 30, 2019 on January 14, 2020 before market open. 

Aphria executives will host a conference call to discuss these results at 8:00 am Eastern Time. To listen to the live call, dial (888) 231-8191 from Canada and the U.S. or (647) 427-7450 from International locations and use the passcode 1575423. A telephone replay will be available approximately two hours after the call concludes through January 28, 2020. To access the recording dial (855) 859-2056 and use the passcode 1575423.

There will also be a simultaneous, live webcast available on the Investors section of Aphria's website at The webcast will be archived for 30 days.

To hear Investorideas interview with Aphria CMO click here.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   

Learn more about our cannabis podcasts at

To hear more podcasts visit: podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About - News that Inspires Big Investing Ideas is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .
Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: Learn more about publishing your news release and our other news services on the newswire and
Global investors must adhere to regulations of each country. Please read privacy policy:

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Follow us on Cannabis Social Media
Download our Mobile App for iPhone and Android  


  Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

No comments:

Post a Comment

Study shows Cannabis terpenes may relieve chemotherapy-induced neuropathic pain

Study shows Cannabis terpenes may relieve chemotherapy-induced neuropathic pain : Study shows Cannabis terpenes may relieve chemotherapy-ind...